SCHEMBL5175980

SCHEMBL5175980

O=C(Nc1ccccc1)Oc1ccc(CCN2CCCC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.59
▸ HRH3 Q9Y5N1 2/20 0.54
▸ HTR1A P08908 1/20 0.54
▸ DRD2 P14416 1/20 0.54
▸ ACHE P22303 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.52
▸ GAA P10253 2/20 0.52
▸ HTT P42858 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ POLB P06746 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ EPHX2 P34913 2/20 0.52
▸ SIGMAR1 Q99720 1/20 0.51
▸ MEN1 O00255 1/20 0.50
▸ FAAH O00519 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.49
▸ LTA4H P09960 1/20 0.49
▸ DRD3 P35462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5174638 0.99 RAB9A (0.58) RAB9AHRH3HTR1ADRD2ACHE
SCHEMBL5174741 0.99 RAB9A (0.58) RAB9AHRH3HTR1ADRD2ACHE
SCHEMBL5175858 0.91 FAAH (0.56) RAB9AHRH3ALDH1A1SMN1; SMN2POLB
SCHEMBL5175918 0.88 RAB9A (0.54) RAB9AHTR1ADRD2ACHEALDH1A1
SCHEMBL5175575 0.85 SIGMAR1 (0.53) RAB9AHTR1ADRD2ACHEALDH1A1
SCHEMBL5174396 0.84 HRH3 (0.65) HRH3HTTEPHX2LTA4H
SCHEMBL5174922 0.84 HRH3 (0.65) HRH3HTTEPHX2LTA4H
SCHEMBL5176444 0.82 SIGMAR1 (0.58) RAB9ADRD2KMT2ASIGMAR1FAAH
SCHEMBL5174308 0.81 RAB9A (0.50) RAB9AHTR1ADRD2ALDH1A1GAA
SCHEMBL5176439 0.80 KDR (0.65) HRH3EPHX2FAAHLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP claimed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO claimed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US claimed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S RAB9A 4254/4885HRH3 159/4885HTR1A 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback